The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
In his new role, Karthik will lead human capital strategy and HR operations across these regions
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
Paves the way for next-gen ultra-precise gas sensing
Subscribe To Our Newsletter & Stay Updated
